On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Starts Selling Cannabis Flower Commercially, Considers Wholesale Distribution

  • Sproutly Canada’s executive team recently announced the company’s first commercial sale of cannabis flower to another licensed producer in Canada
  • The sale marks a major milestone for Sproutly as the beginning of a new revenue stream that is in line with the company’s strategic expansion plans
  • Sproutly also announced that it is awaiting the receipt of a sales license, allowing the company to sell more wholesale craft flower under its new brand, Caliber

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) recently announced its first commercial sale of cannabis flower in Canada. Selling cannabis flower commercially to a recognized and licensed producer is a major milestone, Sproutly CEO Keith Dolo said in a company news release (http://ibn.fm/BqIrC). The shipment marks the beginning of a revenue stream, demonstrating the ability of the Sproutly team to bring the company’s strategy to reality, Dolo concluded.

Currently, Sproutly awaits its sales license from Health Canada. Once the license is received, followed by a thorough inspection, Sproutly may consider selling more wholesale craft flower to ensure consistent revenue generation. Following the receipt of its sales license from Health Canada, Sproutly plans to sell premium cannabis flower under its Caliber brand.

Caliber targets cannabis connoisseurs and high-end consumers. The high-quality manufacturing process and award-winning genetics typical for Sproutly are expected to enable the brand to deliver a superior cannabis experience.

Once the sales license is received, Sproutly plans to launch a Caliber brand campaign, soon to be followed by the distribution of the flower products. Both consumers and retailers will receive vital information about the product and its characteristics, as well as insights about the brand and what makes it different.

The Sproutly cannabis flower is produced by Toronto Herbal Remedies (THR), a fully owned company subsidiary. Its facility relies on modern production technologies and climate control to produce top-shelf premium cannabis flower. THR is in full production and harvesting weekly.

THR has a 16,600 square foot cultivation facility that is strategically located in the greater Toronto area. The facility received its Access to Cannabis for Medical Purposes Regulations (ACMPR) cultivation license from Health Canada in 2018. A processing license was also issued on April 1, 2019.

Sproutly Canada is on a mission to become the leading supplier of water-soluble cannabis bio-natural oils and solutions for cannabis beverage and edibles brands.

Leveraging its water-soluble bio-natural oils and solutions, Sproutly aims to deliver revolutionary brands to international markets through partnerships with well-established local consumer brands. This way, Sproutly will leverage an existing consumer base, expand brand loyalty and support distribution networks to deliver scientific breakthrough across the world.

Sproutly is mainly known for its groundbreaking, patented Aqueous Phytorecovery Process (APP). The technology replaces traditional water-compatible solutions with true and natural water solubility. This mechanism improves the body’s ability to utilize cannabinoids, making their effect almost immediate.

For more information, visit the company’s website at www.Sproutly.ca

NOTE TO INVESTORS: The latest news and updates relating to SRUTF are available in the company’s newsroom at http://ibn.fm/SRUTF

From Our Blog

“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”

April 24, 2024

In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation unfolding in Malawi, East Africa. The Ministry of Health (“MOH”) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping […]

Rotate your device 90° to view site.